The impact of health‐policy‐driven subsidisation of prostate magnetic resonance imaging on transperineal prostate biopsy practice and outcomes

BACKGROUND: From 1 July 2018, the Australian Medicare Benefits Schedule (MBS) introduced rebates for multi‐parametric magnetic resonance imaging (mpMRI) for the workup for prostate cancer (PCa). We aimed to determine if subsidisation of mpMRI prior to transperineal biopsy altered our institution...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Gavin, Reeves, Fairleigh, Perera, Marlon, Kelly, Brian D., Esler, Stephen, Bolton, Damien, Jack, Greg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
To the Drawing Board
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231672/
https://www.ncbi.nlm.nih.gov/pubmed/35783586
http://dx.doi.org/10.1002/bco2.140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231672/
https://www.ncbi.nlm.nih.gov/pubmed/35783586
http://dx.doi.org/10.1002/bco2.140

Ejemplares similares